JPM
JPMorgan Chase & Co.
JPM has a slight edge over PEBO overall, supported by stronger modeled upside and stronger fundamentals.
PEBO
Peoples Bancorp Inc.
PEBO offers stronger valuation, but that advantage does not outweigh its weaker overall profile.
JPM Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| N/A | |
| N/A |
JPM's revenue and profitability are currently healthy. Free cash flow and net leverage aren't meaningful measures for financial services companies like JPM.
PEBO Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Strong | |
| N/A | |
| N/A |
PEBO's profitability is currently strong, and its revenue is stable. Free cash flow and net leverage aren't meaningful measures for financial services companies like PEBO.
JPM PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 9.7x | $231 | -33% |
| Fair | 12x | $287 | -16% |
| Current | 14x | $343 | — |
| Forward | 14x | $343 | — |
| Expensive | 15x | $361 | +5.2% |
Historical ranges are pointers, not guarantees.
JPM's PE is in its expensive range at 14.4x. If earnings grow as analysts expect, today's price would be 13.7x next year's earnings.
PEBO PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 8.3x | $28.05 | -27% |
| Forward | 9.8x | $38.27 | — |
| Fair | 11x | $36.08 | -5.7% |
| Current | 11x | $38.27 | — |
| Expensive | 13x | $44.53 | +16% |
Historical ranges are pointers, not guarantees.
PEBO has the edge over JPM in the historical PE scenario, which offers more potential upside but is not a forecast.
JPM Forward outlook
| Metric | Outlook |
|---|---|
| Stable | |
| Growth | |
| Growth | |
| Improving | |
| Limited | |
| Moderate |
Analysts expect earnings and revenue growth for JPM, with profitability improving.
PEBO Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Growth | |
| Strong growth | |
| Strongly weakening | |
| Limited | |
| Moderate |
Analysts expect earnings and revenue growth for PEBO, but weaker profitability.
JPM Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $24.99 | +4.8% |
| Q3 2026 | $23.85 | +18% |
| Q2 2026 | $23.35 | +20% |
| Q1 2026 | $20.89 | +2.5% |
| Q4 2025 | $20.02 | +1.4% |
| Q3 2025 | $20.20 | +12% |
| Q2 2025 | $19.50 | +8.7% |
| Q1 2025 | $20.38 | +23% |
| Q4 2024 | $19.75 | +22% |
JPM has the edge over PEBO on earnings, with more consistent year-over-year improvement.
PEBO Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $3.89 | +15% |
| Q3 2026 | $3.39 | +19% |
| Q2 2026 | $3.31 | +13% |
| Q1 2026 | $3.12 | -1% |
| Q4 2025 | $2.99 | -9.7% |
| Q3 2025 | $2.86 | -19% |
| Q2 2025 | $2.92 | -17% |
| Q1 2025 | $3.15 | -5.7% |
| Q4 2024 | $3.31 | -3.8% |
PEBO earned $3.39 per share over the past year, up 19% from the year before.
JPM Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $50.2B | +8.1% |
| Q2 2026 | $57.3B | +28% |
| Q1 2026 | $49.8B | +10% |
| Q4 2025 | $45.8B | +7.1% |
| Q3 2025 | $46.4B | +8.8% |
| Q2 2025 | $44.9B | -11% |
| Q1 2025 | $45.3B | +8.1% |
| Q4 2024 | $42.8B | +11% |
JPM has the edge over PEBO on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 40% | -0.2 points |
| Q2 2026 | 48% | +7.3 points |
| Q1 2026 | 41% | +0.5 points |
| Q4 2025 | 37% | -3.2 points |
| Q3 2025 | 40% | +0.6 points |
| Q2 2025 | 41% | -6 points |
| Q1 2025 | 41% | -0.6 points |
| Q4 2024 | 41% | +11 points |
JPM has the edge over PEBO on profitability, with a higher operating margin.
PEBO Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $119.5M | +3.7% |
| Q2 2026 | $113.1M | -1.2% |
| Q1 2026 | $118.7M | +5.6% |
| Q4 2025 | $117.3M | +5.1% |
| Q3 2025 | $115.2M | +1.3% |
| Q2 2025 | $114.5M | +3.8% |
| Q1 2025 | $112.4M | -0.1% |
| Q4 2024 | $111.6M | -0.8% |
PEBO's revenue grew through 2024 and has held roughly level since: $119M last quarter, up 3.7% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 35% | +1.6 points |
| Q2 2026 | 32% | +7.5 points |
| Q1 2026 | 31% | +3.5 points |
| Q4 2025 | 32% | +1.1 points |
| Q3 2025 | 33% | -3 points |
| Q2 2025 | 24% | -8.5 points |
| Q1 2025 | 28% | -5.7 points |
| Q4 2024 | 31% | -7.5 points |
PEBO's operating margin was 35% last quarter, up 1.6 points from the same quarter a year ago.
JPM Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $33.2B | +$78.4B |
| Q2 2026 | -$25.3B | -186% |
| Q1 2026 | -$211.8B | +$40.1B |
| Q4 2025 | $119.7B | -19% |
| Q3 2025 | -$45.2B | +$28.9B |
| Q2 2025 | $29.5B | -23% |
| Q1 2025 | -$251.8B | -$97.7B |
| Q4 2024 | $147.8B | +145% |
JPM's free cash flow was −$84.2B over the past year, against −$120B the year before. Free cash flow isn't a meaningful measure for financial services companies like JPM.
PEBO Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $47.1M | +270% |
| Q2 2026 | $55.2M | +12% |
| Q1 2026 | $33.3M | +5.6% |
| Q4 2025 | $35.2M | -11% |
| Q3 2025 | $12.7M | -62% |
| Q2 2025 | $49.2M | +63% |
| Q1 2025 | $31.5M | -4.9% |
| Q4 2024 | $39.8M | +43% |
PEBO has the edge over JPM on cash generation, producing positive trailing cash flow while its opponent burns cash.
JPM Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.4% | -11.2M shares |
| 1 year | -3.1% | -84.6M shares |
| 3 years | -8.5% | -249M shares |
| 5 years | -11% | -322M shares |
| Available history | -17% | -547M shares |
JPM has the edge over PEBO on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $1.1B |
| Q2 2026 | $6.8B |
| Q1 2026 | $8.3B |
| Q4 2025 | $8.3B |
| Q3 2025 | $8.3B |
| Q2 2025 | $7.5B |
| Q1 2025 | $7.5B |
| Q4 2024 | $4.3B |
JPM spent $24.5B buying back its own shares over the past year, down 11% from the year before.
PEBO Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.3% | +95.9K shares |
| 1 year | +0.7% | +264K shares |
| 3 years | +1.7% | +601K shares |
| 5 years | +83% | +16.2M shares |
| Available history | +73% | +15.1M shares |
PEBO has 36M diluted shares, up 0.7% from a year ago.
| Quarter | Spent |
|---|---|
| Q3 2026 | — |
| Q2 2026 | — |
| Q1 2026 | — |
| Q4 2025 | $383,000 |
| Q3 2025 | — |
| Q2 2025 | $455,000 |
| Q1 2025 | — |
| Q4 2024 | — |
PEBO has spent almost nothing on buybacks in the past year.
JPM Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 0.5x | Very low |
| Q2 2026 | 0.5x | Very low |
| Q1 2026 | 0.6x | Very low |
| Q4 2025 | 0.5x | Very low |
| Q3 2025 | 0.6x | Very low |
| Q2 2025 | 0.5x | Very low |
| Q1 2025 | 0.5x | Very low |
| Q4 2024 | 0.4x | Very low |
JPM's net debt is less than a year of its operating earnings (EBITDA). Net leverage isn't a meaningful measure for financial services companies like JPM.
PEBO Net Leverage
JPM Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 54.8 | Neutral |
| Stochastic | 31.5 | Neutral |
JPM's weekly RSI is 55 (neutral) and its Stochastic is 31 (neutral).
PEBO Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 53.3 | Neutral |
| Stochastic | 47.2 | Neutral |
PEBO's weekly RSI is 53 (neutral) and its Stochastic is 47 (neutral).
JPM PE vs Financial Services Sector
| Metric | JPM | Sector median | Relative |
|---|---|---|---|
| PE | 14x | 13x | 10% above |
| PE % | 76 | 63 | 13 pts above |
JPM is trading at 14x earnings, a 10% premium to the Financial Services sector's median of 13x.
PEBO PE vs Financial Services Sector
| Metric | PEBO | Sector median | Relative |
|---|---|---|---|
| PE | 11x | 13x | 13% below |
| PE % | 59 | 63 | 4 pts below |
PEBO has the edge over JPM on valuation relative to its sector.
JPM Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $336.8 | 1.8% above |
| 20 week MA | $345.3 | 0.7% below |
| 50 week MA | $323.2 | 6.1% above |
| 100 week MA | $298.9 | 15% above |
| 200 week MA | $236.6 | 45% above |
JPM's trend is mixed: it's above four of its five weekly moving averages, and 45% above its 200-week average.
PEBO Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $37.9 | 1.1% above |
| 20 week MA | $39.1 | 2.2% below |
| 50 week MA | $35.5 | 7.7% above |
| 100 week MA | $32.8 | 17% above |
| 200 week MA | $31.0 | 24% above |
PEBO's trend is mixed: it's above four of its five weekly moving averages, and 24% above its 200-week average.
JPM Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $139.1 | $124.5 | -11% |
| 2021 | $124.5 | $157.3 | +26% |
| 2022 | $157.3 | $131.3 | -17% |
| 2023 | $131.3 | $170.1 | +30% |
| 2024 | $170.1 | $241.2 | +42% |
| 2025 | $241.2 | $327.9 | +36% |
| 2026 YTD | $327.9 | $342.8 | +4.5% |
JPM has finished higher in four of the last six years. It's up 4.5% so far in 2026.
PEBO Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $34.7 | $27.0 | -22% |
| 2021 | $27.0 | $31.4 | +16% |
| 2022 | $31.4 | $28.5 | -9.1% |
| 2023 | $28.5 | $33.8 | +18% |
| 2024 | $33.8 | $31.9 | -5.5% |
| 2025 | $31.9 | $30.5 | -4.3% |
| 2026 YTD | $30.5 | $38.3 | +25% |
PEBO has the edge over JPM on returns for 2026, with the stronger performance.